Purvis et al. observed higher circulating plasma levels of ANXA1 in T1D and T2D patients, whereas the exogenous supplementation of ANXA1 improves insulin resistance and prevents the progression of subsequent microvascular complications in mice23,24. This evidence concerns the gene ANXA1 and type 1 diabetes mellitus.